Gregory Weitsman

1.7k total citations
35 papers, 792 citations indexed

About

Gregory Weitsman is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gregory Weitsman has authored 35 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Oncology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gregory Weitsman's work include HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Advanced Fluorescence Microscopy Techniques (5 papers). Gregory Weitsman is often cited by papers focused on HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Advanced Fluorescence Microscopy Techniques (5 papers). Gregory Weitsman collaborates with scholars based in United Kingdom, United States and Israel. Gregory Weitsman's co-authors include Tony Ng, Leigh C. Murphy, Ruth Koren, Amiram Ravid, G. Skliris, Peter H. Watson, Uri Liberman, David Matallanas, Paul R. Barber and David Romano and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Gregory Weitsman

35 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory Weitsman United Kingdom 18 409 288 153 119 101 35 792
Julie H. Ostrander United States 18 568 1.4× 351 1.2× 233 1.5× 94 0.8× 62 0.6× 35 1.1k
Clifton Stephens United States 16 515 1.3× 256 0.9× 97 0.6× 59 0.5× 115 1.1× 23 966
Wendy Béguelin United States 20 763 1.9× 555 1.9× 133 0.9× 96 0.8× 65 0.6× 34 1.4k
Karla Esbona United States 13 327 0.8× 238 0.8× 34 0.2× 83 0.7× 91 0.9× 20 797
Catherine M. Shachaf United States 13 784 1.9× 381 1.3× 126 0.8× 38 0.3× 92 0.9× 22 1.2k
Johanna M. Schafer United States 10 543 1.3× 308 1.1× 107 0.7× 27 0.2× 88 0.9× 18 1.0k
Benjamin Z. Stanton United States 20 1.6k 3.9× 286 1.0× 163 1.1× 55 0.5× 55 0.5× 38 1.9k
Robert W. Hsieh United States 8 625 1.5× 656 2.3× 82 0.5× 42 0.4× 45 0.4× 8 1.4k
Petra Hååg Sweden 19 804 2.0× 185 0.6× 99 0.6× 61 0.5× 80 0.8× 43 1.3k
Flonné Wildes United States 21 849 2.1× 426 1.5× 105 0.7× 128 1.1× 53 0.5× 43 1.4k

Countries citing papers authored by Gregory Weitsman

Since Specialization
Citations

This map shows the geographic impact of Gregory Weitsman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Weitsman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Weitsman more than expected).

Fields of papers citing papers by Gregory Weitsman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Weitsman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Weitsman. The network helps show where Gregory Weitsman may publish in the future.

Co-authorship network of co-authors of Gregory Weitsman

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Weitsman. A scholar is included among the top collaborators of Gregory Weitsman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Weitsman. Gregory Weitsman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Propper, David, Mark Saunders, Debashis Sarker, et al.. (2022). PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer. British Journal of Cancer. 128(2). 245–254. 9 indexed citations
2.
Colomba, Audrey, Martina Fitzek, Roger George, et al.. (2020). A small molecule inhibitor of HER3: a proof-of-concept study. Biochemical Journal. 477(17). 3329–3347. 8 indexed citations
3.
Barber, Paul R., Gregory Weitsman, Katherine Lawler, et al.. (2019). HER2-HER3 Heterodimer Quantification by FRET-FLIM and Patient Subclass Analysis of the COIN Colorectal Trial. JNCI Journal of the National Cancer Institute. 112(9). 944–954. 8 indexed citations
4.
Claus, Jeroen, Gargi Patel, Flavia Autore, et al.. (2018). Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface. eLife. 7. 51 indexed citations
5.
Offin, Michael, Todd Hembrough, Franco Cecchi, et al.. (2018). P1.13-43 Molecular and Imaging Predictors of Response to Ado-Trastuzumab Emtansine in Patients with HER2 Mutant Lung Cancers: An Exploratory Phase 2 Trial. Journal of Thoracic Oncology. 13(10). S599–S599. 4 indexed citations
6.
Ortíz-Zapater, Elena, Richard Lee, William J. Owen, et al.. (2017). MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition. PLoS ONE. 12(1). e0170798–e0170798. 22 indexed citations
7.
Weitsman, Gregory, Paul R. Barber, Lan K. Nguyen, et al.. (2016). HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status. Oncotarget. 7(32). 51012–51026. 25 indexed citations
8.
Jacobs, Bart, Valentina Pomella, Layka Abbasi Asbagh, et al.. (2016). Feedback activation of HER3 attenuates response to EGFR inhibitors in colon cancer cells. Oncotarget. 8(3). 4277–4288. 19 indexed citations
9.
Coban, Oana, Daniel R. Matthews, Daniel J. Rolfe, et al.. (2015). Effect of Phosphorylation on EGFR Dimer Stability Probed by Single-Molecule Dynamics and FRET/FLIM. Biophysical Journal. 108(5). 1013–1026. 35 indexed citations
10.
Battle, Mark, Michel Eisenblaetter, Graeme McRobbie, et al.. (2015). c-Met PET Imaging Detects Early-Stage Locoregional Recurrence of Basal-Like Breast Cancer. Journal of Nuclear Medicine. 57(5). 765–770. 26 indexed citations
11.
Devauges, Viviane, Daniel R. Matthews, James A. Levitt, et al.. (2014). Steady-State Acceptor Fluorescence Anisotropy Imaging under Evanescent Excitation for Visualisation of FRET at the Plasma Membrane. PLoS ONE. 9(10). e110695–e110695. 8 indexed citations
12.
Matthews, Daniel R., Gilbert O. Fruhwirth, Gregory Weitsman, et al.. (2012). A Multi-Functional Imaging Approach to High-Content Protein Interaction Screening. PLoS ONE. 7(4). e33231–e33231. 26 indexed citations
13.
Patel, Gargi, Katherine Lawler, Gregory Weitsman, et al.. (2011). COMBINING PROTEIN INTERACTION AND GENE PROFILING METHODS FOR PREDICTING LAPATINIB RESPONSE. Annals of Oncology. 22. 43–43. 6 indexed citations
14.
Romano, David, David Matallanas, Gregory Weitsman, et al.. (2010). Proapoptotic Kinase MST2 Coordinates Signaling Crosstalk between RASSF1A, Raf-1, and Akt. Cancer Research. 70(3). 1195–1203. 81 indexed citations
15.
Weitsman, Gregory, et al.. (2008). Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha. Breast Cancer Research and Treatment. 118(2). 269–279. 19 indexed citations
16.
Weitsman, Gregory, G. Skliris, Baocheng Peng, et al.. (2006). Assessment of multiple different estrogen receptor-β antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions. Breast Cancer Research and Treatment. 100(1). 23–31. 52 indexed citations
17.
Weitsman, Gregory, Lin Li, G. Skliris, et al.. (2006). Estrogen Receptor-α Phosphorylated at Ser118 Is Present at the Promoters of Estrogen-Regulated Genes and Is Not Altered Due to HER-2 Overexpression. Cancer Research. 66(20). 10162–10170. 69 indexed citations
18.
Weitsman, Gregory, et al.. (2005). Vitamin D sensitizes breast cancer cells to the action of H2O2: Mitochondria as a convergence point in the death pathway. Free Radical Biology and Medicine. 39(2). 266–278. 37 indexed citations
19.
Weitsman, Gregory, Amiram Ravid, Uri Liberman, & Ruth Koren. (2004). The role of p38 MAP kinase in the synergistic cytotoxic action of calcitriol and TNF-α in human breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 89-90(1-5). 361–364. 4 indexed citations
20.
Weitsman, Gregory, Amiram Ravid, Uri Liberman, & Ruth Koren. (2003). Vitamin D enhances caspase‐dependent and ‐independent TNFα‐induced breast cancer cell death: The role of reactive oxygen species and mitochondria. International Journal of Cancer. 106(2). 178–186. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie H. Ostrander Breakdown of academic impact, for papers by Clifton Stephens Breakdown of academic impact, for papers by Wendy Béguelin Breakdown of academic impact, for papers by Karla Esbona Breakdown of academic impact, for papers by Catherine M. Shachaf Breakdown of academic impact, for papers by Johanna M. Schafer Breakdown of academic impact, for papers by Benjamin Z. Stanton Breakdown of academic impact, for papers by Robert W. Hsieh Breakdown of academic impact, for papers by Petra Hååg Breakdown of academic impact, for papers by Flonné Wildes
Rankless by CCL
2026